SWOT Analysis for Monopar Therapeutics Inc - Opportunity

Add SWOT widget to your site/app

Relative Strength Index (RSI) Bullish

Consistent Highest Return Stocks over Five Years

Strong Momentum: Price above short, medium and long term moving averages

Relative Outperformance versus Industry over 1 Month

Rising Net Cash Flow and Cash from Operating activity

Relative Outperformance versus Industry over the Quarter (3 Months)

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Results Screener: Stocks with upcoming results which are seeing positive shifts in share price

Relative Outperformance versus Industry over 1 Month

Near 52 Week High

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Stock gained more than 20% in one month

Increasing profits every quarter for the past 2 quarters

Stock with Low PE (PE < = 10)

Highest Recovery from 52 Week Low

Stocks Outperforming their Industry Price Change in the Quarter

Promoter decreasing their shareholding

Negative profit growth, promoters decreasing shareholding QoQ

PEG greater than Industry PEG

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Top Losers

Low Piotroski Score : Companies with weak financials

Top Losers

Companies with Upcoming Results

Mutual Funds Increased Shareholding in Past Month

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mf buying for 2 months

Stocks rising sharply on very low month volumes